(RTTNews) - Israeli computational chemistry company Evogene Ltd. (EVGN), announced on Wednesday that it has received an additional 180 days from Nasdaq to regain compliance with the minimum $1 bid price requirement. Evogene said Nasdaq staff determined the company is eligible until March 29, 2027 to meet the rule, after failing to comply by September 28. The company will regain compliance, if its shares close at least $1 for a minimum of 10 consecutive business days during the period. Evogene said its shares will continue to trade on the Nasdaq Capital Market under the symbol 'EVGN' and remain listed on the Tel Aviv Stock Exchange.
Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.